Markets.com Logo

VIR

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    4.3172$
  • Previous Close
    4.4219$
  • 52 Week Change
    10.30$
  • Day Range
    -0.10$
  • 52 Week High/Low
    4.155$ - 14.45$
  • Dividend Per Share
    --
  • Market cap
    608 M$
  • EPS
    -0.8
  • Beta
    1.184
  • Volume
    --

About

VIR.US refers to the common stock of Vir Biotechnology, Inc. traded on the NASDAQ stock exchange. Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The ".US" suffix simply indicates that the stock is traded on a United States stock exchange.

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Meta Platforms: Navigating Legal Headwinds and AI Opportunities for Investors

Liam James|--

US Stocks Poised for Potential Rebound Amidst Easing Geopolitical Tensions and Shifting Investor Positioning

Sophia Claire|--
UAE as Global Gold Powerhouse: Analyzing the 2026 Resilience of Dubai’s Gold Trading Ecosystem

UAE as Global Gold Powerhouse: Analyzing the 2026 Resilience of Dubai’s Gold Trading Ecosystem

Ghko B|--
Trade Desk (TTD) Analysis: Is the 2026 Tech Dip a Strategic Entry Point for UAE Investors?

Trade Desk (TTD) Analysis: Is the 2026 Tech Dip a Strategic Entry Point for UAE Investors?

Ghko B|--

Factors

Virology Stocks (VIR.US) Price Factors: Company Performance: Positive clinical trial results, regulatory approvals, and successful product launches drive the price up; conversely, failures or delays lead to price declines. Market Sentiment: Overall investor confidence in the biotechnology sector or concerns about specific viruses or diseases influence demand and, therefore, the stock price. Regulatory Environment: Changes in regulations affecting drug development, approval processes, or pricing policies impact the profitability and attractiveness of virology companies. Competition: The emergence of competing therapies or technologies affects the market share and future revenue potential of virology companies, influencing investor perception and stock value. Pandemic/Epidemic Outbreaks: The outbreak or escalation of viral diseases often increases demand for virology stocks, as investors anticipate increased sales of vaccines, treatments, and diagnostic tools.

People Also Watch

Latest news

Iran-Israel Cyber Warfare Escalates: A Deep Dive into Digital Conflict

Liam James|--

Buffett Sees Few Market Opportunities, Backs Zero Inflation, and Addresses Gates-Epstein Inquiry

Liam James|--

Trump's $400M White House Banquet Hall Project Halted by Federal Judge

Liam James|--

Latest Education Articles

S&P 500, Nasdaq, Dow & Russell 2000: Important Technical Levels Traders Should Watch

S&P 500, Nasdaq, Dow & Russell 2000: Important Technical Levels Traders Should Watch

Ghko B|--
What is CCI strategy: What is the formula for Commodity Channel Index?

What is CCI strategy: What is the formula for Commodity Channel Index?

Ghko B|--
Relative Strength Index (RSI) in trading: RSI indicator buy and sell signals, RSI explained with examples

Relative Strength Index (RSI) in trading: RSI indicator buy and sell signals, RSI explained with examples

Ghko B|--